CoreAge Rx vs Freya Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Freya Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Freya Meds a bad call — it's best for readers interested in doctor and dietitian support who can reconcile the selected price, state eligibility and prepaid cancellation terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Freya Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 67/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the selected offer Homepage starts at $150/month; treatment page lists $297 monthly or $250/month billed and delivered quarterly. Exact formulation, total payment and applicable renewal require confirmation. Full price detailsCurrent selected semaglutide formulation and total quote unknown; homepage starts at $150/month, product page lists $297 monthly or $250/month billed quarterly; earlier listing: From $297/mo (compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the selected offer Homepage starts at $249/month; treatment page lists $390 monthly or $332/month billed and delivered quarterly. Exact formulation, total payment and applicable renewal require confirmation. Full price detailsCurrent selected tirzepatide formulation and total quote unknown; homepage starts at $249/month, product page lists $390 monthly or $332/month billed quarterly; earlier listing: From $390/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Homepage claims fifty-state reach, but terms exclude Alabama, Mississippi and West Virginia; confirm eligibility for the selected service |
| Brand-name access | Not confirmed | Brand ingredient comparisons do not establish a current branded-medication offer; confirm the actual prescription and whether it is compounded. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Freya Meds: Treatment pages list semaglutide $297 monthly or $250/month quarterly; tirzepatide $390 or $332/month quarterly. Homepage lower starts need reconciliation.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.